Results 131 to 140 of about 9,174 (251)
Australasian Journal of Dermatology, EarlyView.ABSTRACT Dupilumab‐associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab‐associated erythema multiforme‐like eruption in a 5‐year‐old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and
Paul Sun Woo Kim +7 more
wiley +1 more source
Australasian Journal of Dermatology, EarlyView.ABSTRACT Background Scabies remains an important public health issue in New Zealand, particularly amongst socioeconomically disadvantaged populations. This study evaluated scabies‐related referrals to a regional dermatology service, including treatment patterns, symptom persistence, and equity outcomes.
Baraa Abuharbid +2 more
wiley +1 more source
Novel Bispecific Engagers Targeting the CεmX Domain of mIgE‐Expressing Cells
Allergy, EarlyView.We developed bispecific TCE & NKCE targeting the CεmX domain of mIgE to eliminate IgE‐producing cells. Both constructs demonstrated potent, specific, dose‐dependent cytotoxicity and selective immune activation in vitro. These results highlight their promise as off‐the‐shelf, potentially curative therapeutics for IgE‐associated allergic diseases ...
Constantin Möller +16 more
wiley +1 more source
Comparison of Loratadine and Cetirizine in Perennial Allergic Rhinitis
Novelty in Biomedicine, 2015 Background: Allergic rhinitis (AR) represents a global health problem, affecting 5-50% of the population worldwide and numerous classes of pharmacological agents are available for its treatment.
Ali Eftekharian, Kiarash Nejatpoor
doaj
Dual action of antihistamines on histamine release
1. Quantitative examinations were made on the effect of benadryl and neoantergan on the histamine release in vitro from chopped skin of dogs and in vivo from rat skin.
Tasaka, Kenji, Yamasaki, Hidemasa
core
Allergy, EarlyView.This randomized, double‐blind, placebo‐controlled trial evaluated the effects of live probiotic and HT postbiotic B. longum CECT 7347 in adults with moderate–severe allergic rhinitis. Postbiotic supplementation for 8 weeks significantly reduced CSMS and dSS, exceeding the established CSMS MCID with a 33% greater improvement, when compared to placebo ...
Ana Cardoso +9 more
wiley +1 more source
Allergy, EarlyView.High‐dose birch‐extract nasal challenge induced synchronous peaks at 4 weeks in serum specific IgE (sIgE) and basophil sensitivity. Mast cell sensitivity via tSPT and sIgG1 and sIgG4 responses peaked later, at 6–8 weeks. Preseasonal allergen exposure attenuated seasonal sIgE increase and prevented further rise in tSPT sensitivity.
N. J. Campion +18 more
wiley +1 more source
Balanced discussion of second-generation antihistamines' data
Therapeutics and Clinical Risk Management, 2016 Rossen Boev,1 Jürgen WG Bentz2 1UCB Pharma, Bulle, Switzerland; 2UCB Pharma, Brussels, Belgium It is with interest that we read the paper “Treatment of allergic rhinitis and urticaria: a review of the newest antihistamine drug bilastine ...
Boev R, Bentz JWG
doaj